Correlation Between Lipigon Pharmaceuticals and Hexagon AB

Can any of the company-specific risk be diversified away by investing in both Lipigon Pharmaceuticals and Hexagon AB at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lipigon Pharmaceuticals and Hexagon AB into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Lipigon Pharmaceuticals AB and Hexagon AB, you can compare the effects of market volatilities on Lipigon Pharmaceuticals and Hexagon AB and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lipigon Pharmaceuticals with a short position of Hexagon AB. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lipigon Pharmaceuticals and Hexagon AB.

Diversification Opportunities for Lipigon Pharmaceuticals and Hexagon AB

0.57

Correlation Coefficient

Lipigon Pharmaceuticals  Hexagon AB

Very weak diversification

The 3 months correlation between Lipigon and Hexagon is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding Lipigon Pharmaceuticals AB and Hexagon AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hexagon AB and Lipigon Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lipigon Pharmaceuticals AB are associated (or correlated) with Hexagon AB. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hexagon AB has no effect on the direction of Lipigon Pharmaceuticals i.e., Lipigon Pharmaceuticals and Hexagon AB go up and down completely randomly.

Pair Corralation between Lipigon Pharmaceuticals and Hexagon AB

Assuming the 90 days trading horizon Lipigon Pharmaceuticals AB is expected to under-perform the Hexagon AB. In addition to that, Lipigon Pharmaceuticals is 3.01 times more volatile than Hexagon AB. It trades about -0.12 of its total potential returns per unit of risk. Hexagon AB is currently generating about 0.3 per unit of volatility. If you would invest  9,316  in Hexagon AB on September 24, 2024 and sell it today you would earn a total of  1,239  from holding Hexagon AB or generate 13.3% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Lipigon Pharmaceuticals AB  vs.  Hexagon AB

Lipigon Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Lipigon Pharmaceuticals AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Hexagon AB

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Hexagon AB are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Hexagon AB is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Lipigon Pharmaceuticals and Hexagon AB

The main advantage of trading using opposite Lipigon Pharmaceuticals and Hexagon AB positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lipigon Pharmaceuticals position performs unexpectedly, Hexagon AB can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hexagon AB will offset losses from the drop in Hexagon AB's long position.

The idea behind Lipigon Pharmaceuticals AB and Hexagon AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.